(Q37871557)

24 August 2017

1 reference

title

Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis (English)

1 reference

24 August 2017

0 references

0 references

1 reference

1 reference

3

Clifton A Baile

1 reference

24 August 2017

Srujana Rayalam

1

1 reference

PubMed ID

21538845

24 August 2017

Mary Anne Della-Fera

series ordinal

2

1 reference

24 August 2017

2 May 2011

1 reference

Molecular Nutrition and Food Research

24 August 2017

1 reference

24 August 2017

55

1 reference

24 August 2017

8

1 reference

24 August 2017

1177-1185

1 reference

Caloric restriction and aging: an update

24 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Ageing: a toast to long life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

The adipocyte life cycle hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Phytochemicals and regulation of the adipocyte life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

On the control of lipolysis in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Effects of resveratrol in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Central administration of resveratrol improves diet-induced diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Genistein inhibits differentiation of primary human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Relationship between the ability to support differentiation of osteoclast-like cells and adipogenesis in murine stromal cells derived from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Mechanisms of disease: is osteoporosis the obesity of bone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Dose-dependency of resveratrol in providing health benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

Effect of resveratrol on fat mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000616

21 January 2018

Identifiers

DOI

10.1002/MNFR.201000616

1 reference

24 August 2017

1 reference

PubMed ID

21538845